DR REDDY'S LABORATORIES (UK) LIMITED
The company operates as the UK pharmaceutical manufacturing subsidiary of Dr. Reddy's Laboratories Ltd, an Indian multinational pharmaceutical group listed on the New York Stock Exchange and Indian stock exchanges.
Get an alert when DR REDDY'S LABORATORIES (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£719K
-47.1% vs 2025
Net assets
£62M
+19.4% highest in 3 filed years
Employees
46
+15% highest in 3 filed years
Profit before tax
£10M
+46.1% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-05-14.
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2022-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £40,293,293 | £67,366,999 | £94,960,784 | +41% | |
| Operating profit | £1,769,207 | £5,382,174 | £8,980,354 | +66.9% | |
| Profit before tax | £2,066,563 | £7,072,034 | £10,330,592 | +46.1% | |
| Net profit | £1,910,224 | £5,803,745 | £10,106,325 | +74.1% | |
| Cash | £559,225 | £1,357,415 | £718,555 | -47.1% | |
| Total assets less current liabilities | £37,068,151 | £52,002,608 | £62,108,864 | +19.4% | |
| Net assets | £37,055,934 | £51,986,287 | £62,092,612 | +19.4% | |
| Equity | £37,055,934 | £51,986,287 | £62,092,612 | +19.4% | |
| Average employees | 45 | 40 | 46 | +15% | |
| Wages | £3,330,328 | £4,526,069 | £4,549,211 | +0.5% | |
| Directors' remuneration | £132,925 | £348,062 | £352,362 | +1.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Operating margin | 4.4% | 8.0% | 9.5% | |
| Net margin | 4.7% | 8.6% | 10.6% | |
| Return on capital employed | 4.8% | 10.3% | 14.5% | |
| Gearing (liabilities / total assets) | — | 27.2% | — | |
| Current ratio | — | 3.65x | 3.17x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- DR REDDY'S LABORATORIES (UK) LIMITED 2002-12-02 → present
- MERIDIAN HEALTHCARE (UK) LIMITED 1997-10-10 → 2002-12-02
- DDSA MANUFACTURING LIMITED 1985-12-02 → 1997-10-10
- D.D.S.A. (U.K.) LIMITED 1983-06-03 → 1985-12-02
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Sadofskys
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company has long term support from the group and as a consequence, the directors believe the company is well placed to manage its business risks successfully despite the uncertain economic outlook. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.”
Significant events
- “The company remains firmly committed to service the UK market needs while continuously evaluating associated risks. With strong processes and mitigation plans in place, we are well-positioned to ensure uninterrupted supply of essential medicines and fulfil our obligations to partners throughout the 2026/27 fiscal year and beyond. Additionally, we do expect continuation of ongoing negotiations regarding the Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) what will influence the UK market's attractiveness for new product launches.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BAHETI, Anup Kumar | Secretary | 2022-05-17 | — | — |
| AGHANIAN, Patrick | Director | 2020-03-04 | Jan 1965 | Iranian |
| KUMAR, Manoj | Director | 2025-04-30 | Aug 1985 | Indian |
| MANNAM, Venkata Narsimham | Director | 2010-05-03 | May 1968 | Indian |
| OBERTE, Kristine | Director | 2024-04-30 | Aug 1978 | Latvian |
| REDDY, Kallam Satish | Director | 2005-03-14 | Jun 1967 | Indian |
| YASSAR, Mohammed | Director | 2021-05-06 | Apr 1981 | Indian |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BANDALI, Abbas | Secretary | 2012-07-29 | 2017-08-04 |
| BRODRICK, Andrew, Dr | Secretary | 1999-05-10 | 2002-04-11 |
| DAVIES, Robin | Secretary | 2002-04-11 | 2004-07-30 |
| NATU, Sameer | Secretary | 2004-09-27 | 2012-07-29 |
| SANE, Ramanjaneyulu | Secretary | 2017-08-04 | 2022-05-17 |
| SOLOMON, Charmian, Mrs. | Secretary | — | 1996-11-25 |
| SPURLING, Alan Malcolm | Secretary | 1996-11-25 | 1998-01-05 |
| VOERMAN, Peter | Secretary | 1998-01-05 | 1999-05-10 |
| BONTHU, Viswanatha | Director | 2002-04-11 | 2013-03-31 |
| BRODRICK, Andrew, Dr | Director | 1999-05-10 | 2002-04-11 |
| CHAPLIN, David Andrew | Director | 2018-02-20 | 2019-01-31 |
| DAVIES, Robin | Director | 1999-05-10 | 2004-07-30 |
| DE RIJCKE, Pieter Willem Jacobus | Director | 1996-11-25 | 1999-05-10 |
| EWERS, Michael | Director | 2012-05-10 | 2014-11-27 |
| GREGORY, Neil Windsor | Director | 1999-05-10 | 2005-03-14 |
| HARTMAN, Mark | Director | 2002-04-11 | 2008-10-29 |
| HAZELEBACH, Gerard Willem | Director | 1998-07-01 | 1999-05-10 |
| KILHAM, Jonathan Paul | Director | 2010-05-03 | 2013-03-31 |
| KOHLI, Subir | Director | 2013-04-10 | 2019-11-29 |
| MCAULIFFE, Sean | Director | 2020-01-01 | 2021-05-31 |
| OTTEN, Edwin | Director | 1997-05-01 | 1998-05-07 |
| REID, Cameron | Director | 2002-04-11 | 2004-04-05 |
| SAWHNEY, Arun | Director | 2004-04-13 | 2008-04-29 |
| SHEPPARD, Alan | Director | 2004-11-01 | 2007-03-31 |
| SOLOMON, Montague Cecil, Dr | Director | — | 1996-11-25 |
| TROCHE, Clemens Johannes | Director | 2014-11-27 | 2019-05-15 |
| VAN HEDEL, Theodorus Johannes Maria | Director | 1998-05-07 | 1999-05-10 |
| VASUDEVAN, Vishar Subramanian | Director | 2002-05-10 | 2010-03-30 |
| VOERMAN, Peter | Director | 1998-01-05 | 1999-05-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Reddys Laboratories (Eu) Ltd | Corporate entity | Shares 75–100% | 2016-04-07 | Active |
Filing timeline
Last 20 of 187 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-12 | AA | accounts | Accounts with accounts type full | |
| 2025-05-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-06 | AA | accounts | Accounts with accounts type full | |
| 2025-05-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-03 | AA | accounts | Accounts with accounts type full | |
| 2024-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-30 | AA | accounts | Accounts with accounts type full | |
| 2023-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-15 | AA | accounts | Accounts with accounts type full | |
| 2022-09-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-06-17 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-05-19 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-05-19 | AP03 | officers | Appoint person secretary company with name date | |
| 2022-05-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-05-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-05-03 | CH01 | officers | Change person director company with change date | |
| 2021-12-22 | AA | accounts | Accounts with accounts type full | |
| 2021-06-20 | TM01 | officers | Termination director company with name termination date | |
| 2021-05-17 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.